- Home
- MDXG vs AOD Comparison
MDXG vs AOD Comparison
Compare MDXG & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- AOD
- Stock Information
- Founded
- MDXG 2006
- AOD 2006
- Country
- MDXG United States
- AOD United Kingdom
- Employees
- MDXG N/A
- AOD N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- AOD Investment Managers
- Sector
- MDXG Health Care
- AOD Finance
- Exchange
- MDXG Nasdaq
- AOD Nasdaq
- Market Cap
- MDXG 1.0B
- AOD 988.9M
- IPO Year
- MDXG N/A
- AOD N/A
- Fundamental
- Price
- MDXG $6.77
- AOD $9.66
- Analyst Decision
- MDXG Buy
- AOD
- Analyst Count
- MDXG 1
- AOD 0
- Target Price
- MDXG $12.00
- AOD N/A
- AVG Volume (30 Days)
- MDXG 619.7K
- AOD 423.5K
- Earning Date
- MDXG 10-29-2025
- AOD 01-01-0001
- Dividend Yield
- MDXG N/A
- AOD 12.95%
- EPS Growth
- MDXG N/A
- AOD 213.63
- EPS
- MDXG 0.21
- AOD 1.93
- Revenue
- MDXG $363,774,000.00
- AOD $72,962,082.00
- Revenue This Year
- MDXG $12.68
- AOD N/A
- Revenue Next Year
- MDXG $8.18
- AOD N/A
- P/E Ratio
- MDXG $32.20
- AOD $4.44
- Revenue Growth
- MDXG 6.85
- AOD N/A
- 52 Week Low
- MDXG $5.64
- AOD $6.99
- 52 Week High
- MDXG $10.14
- AOD $9.14
- Technical
- Relative Strength Index (RSI)
- MDXG 46.80
- AOD 58.32
- Support Level
- MDXG $6.58
- AOD $9.59
- Resistance Level
- MDXG $6.86
- AOD $9.66
- Average True Range (ATR)
- MDXG 0.20
- AOD 0.11
- MACD
- MDXG -0.01
- AOD -0.00
- Stochastic Oscillator
- MDXG 36.17
- AOD 77.38
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.